{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:34:16Z","timestamp":1794332056211,"version":"4.9.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Funded Postdoctoral Researchers Program","award":["GZC20230651"],"award-info":[{"award-number":["GZC20230651"]}]},{"name":"the STI2030-Major Projects","award":["2021ZD0201001"],"award-info":[{"award-number":["2021ZD0201001"]}]},{"name":"the STI2030-Major Projects","award":["2021ZD0201001"],"award-info":[{"award-number":["2021ZD0201001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971025"],"award-info":[{"award-number":["81971025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Amyloid-\u03b2 (A\u03b2) readily misfolds into neurotoxic aggregates, generating high levels of reactive oxygen species (ROS), leading to progressive oxidative damage and ultimately cell death. Therefore, simultaneous inhibition of A\u03b2 aggregation and scavenging of ROS may be a promising therapeutic strategy to alleviate Alzheimer\u2019s disease pathology. Based on the previously developed antibody 1F12 that targets all forms of A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    , we developed an A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    and ROS dual-targeting nanocomposite using biodegradable mesoporous silica nanoparticles as carriers to load ultra-small cerium oxide nanocrystals (bMSNs@Ce-1F12). By modifying the brain-targeted rabies virus glycoprotein 29 (RVG29-bMSNs@Ce-1F12), this intelligent nanocomposite can efficiently target brain A\u03b2-rich regions. Combined with peripheral and central nervous system treatments, RVG29-bMSNs@Ce-1F12 can significantly alleviate AD symptoms by inhibiting A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    misfolding, accelerating A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    clearance, and scavenging ROS. Furthermore, this synergistic effect of ROS scavenging and A\u03b2 clearance exhibited by this A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    and ROS dual-targeted strategy also reduced the burden of hyperphosphorylated tau, alleviated glial cell activation, and ultimately improved cognitive function in APP\/PS1 mice. Our findings indicate that RVG29-bMSNs@Ce-1F12 is a promising nanodrug that can facilitate multi-target treatment of AD.\n                  <\/jats:p>","DOI":"10.1186\/s12951-024-02543-z","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T01:01:58Z","timestamp":1716426118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["A\u03b242 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Liding","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"7662","key":"2543_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/547153a","volume":"547","author":"E McDade","year":"2017","unstructured":"McDade E, Bateman RJ. Stop Alzheimer\u2019s before it starts. Nature. 2017;547(7662):153\u20135.","journal-title":"Nature"},{"issue":"1","key":"2543_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM. Alzheimer\u2019s disease. Eur J Neurol. 2018;25(1):59\u201370.","journal-title":"Eur J Neurol"},{"issue":"01","key":"2543_CR3","doi-asserted-by":"publisher","first-page":"2230001","DOI":"10.1142\/S1793545822300014","volume":"15","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liang X, Zhang Z, Luo H. Cerebrospinal fluid and blood biomarkers in the diagnostic assays of Alzheimer\u2019s disease. J Innov Opt Heal Sci. 2022;15(01):2230001.","journal-title":"J Innov Opt Heal Sci"},{"issue":"10","key":"2543_CR4","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(10):5481\u2013503.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"2543_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41557-020-0452-1","volume":"12","author":"TCT Michaels","year":"2020","unstructured":"Michaels TCT, \u0160ari\u0107 A, Curk S, Bernfur K, Arosio P, Meisl G, et al. Dynamics of oligomer populations formed during the aggregation of Alzheimer\u2019s A\u03b242 peptide. Nat Chem. 2020;12(5):445\u201351.","journal-title":"Nat Chem"},{"issue":"2","key":"2543_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1039\/C6CS00731G","volume":"46","author":"SJ Lee","year":"2017","unstructured":"Lee SJ, Nam E, Lee HJ, Savelieff MG, Lim MH. Towards an understanding of amyloid-\u03b2 oligomers: characterization, toxicity mechanisms, and inhibitors. Chem Soc Rev. 2017;46(2):310\u201323.","journal-title":"Chem Soc Rev"},{"issue":"3","key":"2543_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, De Strooper B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci. 2012;15(3):349\u201357.","journal-title":"Nat Neurosci"},{"issue":"1","key":"2543_CR8","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/s41467-019-09477-3","volume":"10","author":"S De","year":"2019","unstructured":"De S, Wirthensohn DC, Flagmeier P, Hughes C, Aprile FA, Ruggeri FS, et al. Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms. Nat Commun. 2019;10(1):1541.","journal-title":"Nat Commun"},{"issue":"23","key":"2543_CR9","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1007\/s00018-020-03464-4","volume":"77","author":"KE Marshall","year":"2020","unstructured":"Marshall KE, Vadukul DM, Staras K, Serpell LC. Misfolded amyloid-\u03b2-42 impairs the endosomal-lysosomal pathway. Cell Mol Life Sci. 2020;77(23):5031\u201343.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"2543_CR10","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H. Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791\u2013800.","journal-title":"Neurology"},{"key":"2543_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol. 2018;14:450\u201364.","journal-title":"Redox Biol"},{"issue":"11","key":"2543_CR12","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1111\/jth.15055","volume":"18","author":"C Visconte","year":"2020","unstructured":"Visconte C, Canino J, Vismara M, Guidetti GF, Raimondi S, Pula G, et al. Fibrillar amyloid peptides promote platelet aggregation through the coordinated action of ITAM- and ROS-dependent pathways. J Thromb Haemost. 2020;18(11):3029\u201342.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2543_CR13","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1073\/pnas.91.8.3270","volume":"91","author":"K Hensley","year":"1994","unstructured":"Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A. 1994;91(8):3270\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2543_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2014.06.006","volume":"74","author":"DA Butterfield","year":"2014","unstructured":"Butterfield DA. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment. Free Radic Biol Med. 2014;74:157\u201374.","journal-title":"Free Radic Biol Med"},{"key":"2543_CR15","doi-asserted-by":"publisher","first-page":"120483","DOI":"10.1016\/j.biomaterials.2020.120483","volume":"267","author":"L Gong","year":"2021","unstructured":"Gong L, Zhang X, Ge K, Yin Y, Machuki JO, Yang Y, et al. Carbon Nitride-based nanocaptor: an intelligent nanosystem with metal ions chelating effect for enhanced magnetic targeting phototherapy of Alzheimer\u2019s disease. Biomaterials. 2021;267:120483.","journal-title":"Biomaterials"},{"issue":"18","key":"2543_CR16","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1089\/ars.2017.7272","volume":"28","author":"C Garza-Lomb\u00f3","year":"2018","unstructured":"Garza-Lomb\u00f3 C, Posadas Y, Quintanar L, Gonsebatt ME, Franco R. Neurotoxicity linked to dysfunctional metal ion homeostasis and xenobiotic metal exposure: redox signaling and oxidative stress. Antioxid Redox Sign. 2018;28(18):1669\u2013703.","journal-title":"Antioxid Redox Sign"},{"issue":"12","key":"2543_CR17","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S. Aducanumab: first approval. Drugs. 2021;81(12):1437\u201343.","journal-title":"Drugs"},{"issue":"1","key":"2543_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"2543_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13195-022-01110-8","volume":"14","author":"RJ Bateman","year":"2022","unstructured":"Bateman RJ, Cummings J, Schobel S, Salloway S, Vellas B, Boada M, et al. Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14(1):178.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2543_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12951-021-01111-z","volume":"19","author":"L Zhang","year":"2021","unstructured":"Zhang L, Du X, Su Y, Niu S, Li Y, Liang X, et al. Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay. J Nanobiotechnol. 2021;19(1):366.","journal-title":"J Nanobiotechnol"},{"key":"2543_CR21","doi-asserted-by":"publisher","first-page":"723317","DOI":"10.3389\/fnmol.2021.723317","volume":"14","author":"L Zhang","year":"2021","unstructured":"Zhang L, Yang C, Li Y, Niu S, Liang X, Zhang Z, et al. Dynamic changes in the levels of Amyloid-\u03b2(42) species in the brain and periphery of APP\/PS1 mice and their significance for Alzheimer\u2019s disease. Front Mol Neurosci. 2021;14:723317.","journal-title":"Front Mol Neurosci"},{"issue":"21","key":"2543_CR22","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","volume":"62","author":"M Gupta","year":"2019","unstructured":"Gupta M, Lee HJ, Barden CJ, Weaver DF. The blood-brain barrier (BBB) score. J Med Chem. 2019;62(21):9824\u201336.","journal-title":"J Med Chem"},{"issue":"5","key":"2543_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen GC, Meyer AH, Bell RD, Zhang W. Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov. 2021;20(5):362\u201383.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2543_CR24","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1021\/acsnano.0c10035","volume":"15","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhan L, Qin Z, Sackrison J, Bischof JC. Ultrasensitive and highly specific lateral flow assays for point-of-care diagnosis. ACS Nano. 2021;15(3):3593\u2013611.","journal-title":"ACS Nano"},{"issue":"27","key":"2543_CR25","doi-asserted-by":"publisher","first-page":"e2201322","DOI":"10.1002\/adma.202201322","volume":"34","author":"N Yin","year":"2022","unstructured":"Yin N, Zhao Y, Liu C, Yang Y, Wang ZH, Yu W, et al. Engineered nanoerythrocytes alleviate central nervous system inflammation by regulating the polarization of inflammatory microglia. Adv Mater. 2022;34(27):e2201322.","journal-title":"Adv Mater"},{"key":"2543_CR26","doi-asserted-by":"publisher","first-page":"113953","DOI":"10.1016\/j.addr.2021.113953","volume":"177","author":"A Garc\u00eda-Fern\u00e1ndez","year":"2021","unstructured":"Garc\u00eda-Fern\u00e1ndez A, Sancen\u00f3n F, Mart\u00ednez-M\u00e1\u00f1ez R. Mesoporous silica nanoparticles for pulmonary drug delivery. Adv Drug Deliv Rev. 2021;177:113953.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"2543_CR27","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1021\/acsnano.2c11112","volume":"17","author":"X Li","year":"2023","unstructured":"Li X, Li Y, Yu C, Bao H, Cheng S, Huang J, et al. ROS-responsive janus Au\/mesoporous silica core\/shell nanoparticles for drug delivery and long-term CT imaging tracking of MSCs in pulmonary fibrosis treatment. ACS Nano. 2023;17(7):6387\u201399.","journal-title":"ACS Nano"},{"issue":"1","key":"2543_CR28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12951-022-01642-z","volume":"20","author":"N Liu","year":"2022","unstructured":"Liu N, Yang C, Liang X, Cao K, Xie J, Luo Q, et al. Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain A\u03b2 burden and improves olfactory dysfunction of APP\/PS1 mice by nasal delivery. J Nanobiotechnol. 2022;20(1):439.","journal-title":"J Nanobiotechnology"},{"key":"2543_CR29","doi-asserted-by":"publisher","first-page":"120191","DOI":"10.1016\/j.biomaterials.2020.120191","volume":"256","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Jiao X, Fan W, Yang Z, Wen Y, Chen X. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics. Biomaterials. 2020;256:120191.","journal-title":"Biomaterials"},{"issue":"37","key":"2543_CR30","doi-asserted-by":"publisher","first-page":"42056","DOI":"10.1021\/acsami.0c08778","volume":"12","author":"V Baldim","year":"2020","unstructured":"Baldim V, Yadav N, Bia N, Graillot A, Loubat C, Singh S, et al. Polymer-coated cerium oxide nanoparticles as oxidoreductase-like catalysts. ACS Appl Mater Interfaces. 2020;12(37):42056\u201366.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"51","key":"2543_CR31","doi-asserted-by":"publisher","first-page":"e2102342","DOI":"10.1002\/smll.202102342","volume":"17","author":"MS Lord","year":"2021","unstructured":"Lord MS, Berret JF, Singh S, Vinu A, Karakoti AS. Redox active cerium oxide nanoparticles: current status and burning issues. Small. 2021;17(51):e2102342.","journal-title":"Small"},{"issue":"14","key":"2543_CR32","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1021\/acs.est.7b01130","volume":"51","author":"RC Merrifield","year":"2017","unstructured":"Merrifield RC, Arkill KP, Palmer RE, Lead JR. A high resolution study of dynamic changes of ce(2)O(3) and CeO(2) nanoparticles in complex environmental media. Environ Sci Technol. 2017;51(14):8010\u20136.","journal-title":"Environ Sci Technol"},{"issue":"1","key":"2543_CR33","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1038\/s41467-019-13316-w","volume":"10","author":"X Xie","year":"2019","unstructured":"Xie X, Nie H, Zhou Y, Lian S, Mei H, Lu Y, et al. Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles. Nat Commun. 2019;10(1):5476.","journal-title":"Nat Commun"},{"issue":"2","key":"2543_CR34","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1021\/acsnano.7b07625","volume":"12","author":"Q Chen","year":"2018","unstructured":"Chen Q, Du Y, Zhang K, Liang Z, Li J, Yu H, et al. Tau-targeted multifunctional nanocomposite for combinational therapy of Alzheimer\u2019s disease. ACS Nano. 2018;12(2):1321\u201338.","journal-title":"ACS Nano"},{"issue":"20","key":"2543_CR35","doi-asserted-by":"publisher","first-page":"19740","DOI":"10.1021\/acsnano.3c03195","volume":"17","author":"Y Huang","year":"2023","unstructured":"Huang Y, Nahar S, Alam MM, Hu S, McVicar DW, Yang D. Reactive oxygen species-sensitive biodegradable mesoporous silica nanoparticles harboring theraVac elicit tumor-specific immunity for colon tumor treatment. ACS Nano. 2023;17(20):19740\u201352.","journal-title":"ACS Nano"},{"issue":"26","key":"2543_CR36","doi-asserted-by":"publisher","first-page":"E5849","DOI":"10.1073\/pnas.1803539115","volume":"115","author":"X Yang","year":"2018","unstructured":"Yang X, Meisl G, Frohm B, Thulin E, Knowles TPJ, Linse S. On the role of sidechain size and charge in the aggregation of A\u03b242 with familial mutations. Proc Natl Acad Sci U S A. 2018;115(26):E5849\u201358.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2543_CR37","doi-asserted-by":"publisher","first-page":"7459","DOI":"10.1007\/s12274-022-5354-4","volume":"16","author":"L Zhang","year":"2023","unstructured":"Zhang L, Su Y, Liang X, Cao K, Luo Q, Luo H. Ultrasensitive and point-of-care detection of plasma phosphorylated tau in Alzheimer\u2019s disease using colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay. Nano Res. 2023;16(5):7459\u201369.","journal-title":"Nano Res"},{"issue":"2","key":"2543_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1523\/JNEUROSCI.4622-09.2010","volume":"30","author":"DW Wesson","year":"2010","unstructured":"Wesson DW, Levy E, Nixon RA, Wilson DA. Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer\u2019s disease mouse model. J Neurosci. 2010;30(2):505\u201314.","journal-title":"J Neurosci"},{"issue":"5","key":"2543_CR39","doi-asserted-by":"publisher","first-page":"e10111011","DOI":"10.1016\/j.neurobiolaging.2011.10.028","volume":"33","author":"M Maesako","year":"2012","unstructured":"Maesako M, Uemura K, Kubota M, Kuzuya A, Sasaki K, Asada M, et al. Environmental enrichment ameliorated high-fat diet-induced A\u03b2 deposition and memory deficit in APP transgenic mice. Neurobiol Aging. 2012;33(5):e10111011\u20131023.","journal-title":"Neurobiol Aging"},{"key":"2543_CR40","doi-asserted-by":"publisher","first-page":"119822","DOI":"10.1016\/j.biomaterials.2020.119822","volume":"237","author":"H Zhou","year":"2020","unstructured":"Zhou H, Gong Y, Liu Y, Huang A, Zhu X, Liu J, et al. Intelligently thermoresponsive flower-like hollow nano-ruthenium system for sustained release of nerve growth factor to inhibit hyperphosphorylation of tau and neuronal damage for the treatment of Alzheimer\u2019s disease. Biomaterials. 2020;237:119822.","journal-title":"Biomaterials"},{"key":"2543_CR41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.biomaterials.2018.12.027","volume":"197","author":"J Sun","year":"2019","unstructured":"Sun J, Wei C, Liu Y, Xie W, Xu M, Zhou H, et al. Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer\u2019s disease. Biomaterials. 2019;197:417\u201331.","journal-title":"Biomaterials"},{"key":"2543_CR42","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.msec.2014.05.070","volume":"42","author":"K Stang","year":"2014","unstructured":"Stang K, Krajewski S, Neumann B, Kurz J, Post M, Stoppelkamp S, et al. Hemocompatibility testing according to ISO 10993-4: discrimination between pyrogen- and device-induced hemostatic activation. Mater Sci Eng C Mater Biol Appl. 2014;42:422\u20138.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"9","key":"2543_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/ar050069h","volume":"39","author":"R Wetzel","year":"2006","unstructured":"Wetzel R. Kinetics and thermodynamics of amyloid fibril assembly. Acc Chem Res. 2006;39(9):671\u20139.","journal-title":"Acc Chem Res"},{"issue":"2","key":"2543_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"F Panza","year":"2019","unstructured":"Panza F, Lozupone M, Logroscino G, Imbimbo BP. A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2019;15(2):73\u201388.","journal-title":"Nat Rev Neurol"},{"key":"2543_CR45","doi-asserted-by":"publisher","first-page":"617588","DOI":"10.3389\/fnagi.2021.617588","volume":"13","author":"A Misrani","year":"2021","unstructured":"Misrani A, Tabassum S, Yang L. Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Front Aging Neurosci. 2021;13:617588.","journal-title":"Front Aging Neurosci"},{"issue":"18","key":"2543_CR46","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.1039\/D1SC00153A","volume":"12","author":"L Lei","year":"2021","unstructured":"Lei L, Zou Z, Liu J, Xu Z, Fu Y, Tian Y, et al. Multifunctional peptide-assembled micelles for simultaneously reducing amyloid-\u03b2 and reactive oxygen species. Chem Sci. 2021;12(18):6449\u201357.","journal-title":"Chem Sci"},{"issue":"5","key":"2543_CR47","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, et al. TREM2 is a receptor for \u03b2-Amyloid that mediates microglial function. Neuron. 2018;97(5):1023\u2013e10311027.","journal-title":"Neuron"},{"key":"2543_CR48","doi-asserted-by":"publisher","first-page":"102010","DOI":"10.1016\/j.redox.2021.102010","volume":"44","author":"X Han","year":"2021","unstructured":"Han X, Xu T, Fang Q, Zhang H, Yue L, Hu G, et al. Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy. Redox Biol. 2021;44:102010.","journal-title":"Redox Biol"},{"key":"2543_CR49","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R, Guo J, Ye XY, Xie Y, Xie T. Oxidative stress: the core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res Rev. 2022;77:101619.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2543_CR50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","volume":"104","author":"M Perluigi","year":"2024","unstructured":"Perluigi M, Di Domenico F, Butterfield DA. Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiol Rev. 2024;104(1):103\u201397.","journal-title":"Physiol Rev"},{"issue":"1","key":"2543_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-024-00702-2","volume":"19","author":"M Calvo-Rodriguez","year":"2024","unstructured":"Calvo-Rodriguez M, Kharitonova EK, Snyder AC, Hou SS, Sanchez-Mico MV, Das S, et al. Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid \u03b2 aggregates in vivo in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2024;19(1):6.","journal-title":"Mol Neurodegener"},{"key":"2543_CR52","doi-asserted-by":"publisher","first-page":"352723","DOI":"10.1155\/2015\/352723","volume":"2015","author":"Z Liu","year":"2015","unstructured":"Liu Z, Li T, Li P, Wei N, Zhao Z, Liang H, et al. The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer\u2019s disease. Oxid Med Cell Longev. 2015;2015:352723.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"2543_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/nan.12084","volume":"40","author":"S Mondrag\u00f3n-Rodr\u00edguez","year":"2014","unstructured":"Mondrag\u00f3n-Rodr\u00edguez S, Perry G, Luna-Mu\u00f1oz J, Acevedo-Aquino MC, Williams S. Phosphorylation of tau protein at sites ser(396\u2013404) is one of the earliest events in Alzheimer\u2019s disease and Down syndrome. Neuropathol Appl Neurobiol. 2014;40(2):121\u201335.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"2543_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2990.2007.00853.x","volume":"34","author":"S Mondrag\u00f3n-Rodr\u00edguez","year":"2008","unstructured":"Mondrag\u00f3n-Rodr\u00edguez S, Mena R, Binder LI, Smith MA, Perry G, Garc\u00eda-Sierra F. Conformational changes and cleavage of tau in pick bodies parallel the early processing of tau found in Alzheimer pathology. Neuropathol Appl Neurobiol. 2008;34(1):62\u201375.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"2543_CR55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-020-02251-6","volume":"141","author":"L Arag\u00e3o Gomes","year":"2021","unstructured":"Arag\u00e3o Gomes L, Uytterhoeven V, Lopez-Sanmartin D, Tom\u00e9 SO, Tousseyn T, Vandenberghe R, et al. Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation. Acta Neuropathol. 2021;141(2):173\u201392.","journal-title":"Acta Neuropathol"},{"key":"2543_CR56","doi-asserted-by":"publisher","first-page":"114935","DOI":"10.1016\/j.bios.2022.114935","volume":"222","author":"L Zhang","year":"2023","unstructured":"Zhang L, Cao K, Su Y, Hu S, Liang X, Luo Q, et al. Colorimetric and surface-enhanced Raman scattering dual-mode magnetic immunosensor for ultrasensitive detection of blood phosphorylated tau in Alzheimer\u2019s disease. Biosens Bioelectron. 2023;222:114935.","journal-title":"Biosens Bioelectron"},{"issue":"5534","key":"2543_CR57","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J G\u00f6tz","year":"2001","unstructured":"G\u00f6tz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 2001;293(5534):1491\u20135.","journal-title":"Science"},{"issue":"3","key":"2543_CR58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron. 2004;43(3):321\u201332.","journal-title":"Neuron"},{"issue":"1","key":"2543_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12974-021-02182-3","volume":"18","author":"XY Sun","year":"2021","unstructured":"Sun XY, Li LJ, Dong QX, Zhu J, Huang YR, Hou SJ, et al. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer\u2019s disease. J Neuroinflamm. 2021;18(1):131.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"2543_CR60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/jamaneurol.2015.2952","volume":"73","author":"RO Roberts","year":"2016","unstructured":"Roberts RO, Christianson TJ, Kremers WK, Mielke MM, Machulda MM, Vassilaki M, et al. Association between olfactory dysfunction and amnestic mild cognitive impairment and Alzheimer disease dementia. JAMA Neurol. 2016;73(1):93\u2013101.","journal-title":"JAMA Neurol"},{"issue":"3","key":"2543_CR61","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nprot.2006.170","volume":"1","author":"RM Deacon","year":"2006","unstructured":"Deacon RM. Assessing nest building in mice. Nat Protoc. 2006;1(3):1117\u20139.","journal-title":"Nat Protoc"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02543-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02543-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02543-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T02:04:39Z","timestamp":1716429879000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02543-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2543"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02543-z","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving experimental animals were carried out under guidelines approved by the Institutional Animal Care and Use Committee of Huazhong University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The online version contains supplementary material available at https:\/\/doi.Synthetic scheme of protein-modified bMSNs@Ce (Fig.\n                      \n                      ); The size and Zeta potential of Nanoparticles (Fig.\n                      \n                      ); XPS analysis of RVG29-bMSNs@Ce-1F12 (Fig.\n                      \n                      ); The AFM image of RVG29-bMSNs@Ce-1F12 (Fig.\n                      \n                      ); Characterization of RVG29-bMSNs@Ce-1F12 (Fig.\n                      \n                      ); Hydroxyl radical scavenging test (Fig.\n                      \n                      ); Biocompatibility assay (Fig.\n                      \n                      ); Characterization of A\u03b2 plaque stained with 1F12 and RVG29-bMSNs@Ce (Fig.\n                      \n                      ); Evaluation of the ability of RVG29-bMSNs@Ce-1F12 to inhibit A\u03b2 aggregation (Fig.\n                      \n                      ); RVG29-bMSNs@Ce-1F12 alleviates A\u03b2<sub>42<\/sub> aggregates-induced microgliosis (Fig.\n                      \n                      0); Biodistribution of 1F12 and RVG29-bMSNs@Ce (Fig.\n                      \n                      1); IP-Western blot analysis of A\u03b2<sub>42<\/sub> level in plasma of APP\/PS1 mice after different treatments (Fig.\n                      \n                      2); Soluble p-tau<sup>396,404<\/sup> levels in the brains of mice treated with RVG29-bMSNs@Ce-1F12, 1F12, RVG29-bMSNs@Ce, and saline were detected by dot blot (Fig.\n                      \n                      3); RVG29-bMSNs@Ce-1F12 ameliorates learning and memory impairments in APP\/PS1 mice\u00a0(Fig.\n                      \n                      4).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Supporting information"}}],"article-number":"278"}}